| Literature DB >> 31113851 |
Nobuhiko Kayagaki1, Bettina L Lee2, Irma B Stowe2, Opher S Kornfeld2, Karen O'Rourke2, Kathleen M Mirrashidi2, Benjamin Haley3, Colin Watanabe4, Merone Roose-Girma3, Zora Modrusan3, Sarah Kummerfeld4, Rohit Reja4, Yafei Zhang5, Vicky Cho5,6, T Daniel Andrews6, Lucy X Morris5, Christopher C Goodnow7,8, Edward M Bertram5,6, Vishva M Dixit1.
Abstract
Gasdermin-D (GSDMD) is cleaved by caspase-1, caspase-4, and caspase-11 in response to canonical and noncanonical inflammasome activation. Upon cleavage, GSDMD oligomerizes and forms plasma membrane pores, resulting in interleukin-1β (IL-1β) secretion, pyroptotic cell death, and inflammatory pathologies, including periodic fever syndromes and septic shock-a plague on modern medicine. Here, we showed that IRF2, a member of the interferon regulatory factor (IRF) family of transcription factors, was essential for the transcriptional activation of GSDMD. A forward genetic screen with N-ethyl-N-nitrosourea (ENU)-mutagenized mice linked IRF2 to inflammasome signaling. GSDMD expression was substantially attenuated in IRF2-deficient macrophages, endothelial cells, and multiple tissues, which corresponded with reduced IL-1β secretion and inhibited pyroptosis. Mechanistically, IRF2 bound to a previously uncharacterized but unique site within the GSDMD promoter to directly drive GSDMD transcription for the execution of pyroptosis. Disruption of this single IRF2-binding site abolished signaling by both the canonical and noncanonical inflammasomes. Together, our data illuminate a key transcriptional mechanism for expression of the gene encoding GSDMD, a critical mediator of inflammatory pathologies.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31113851 DOI: 10.1126/scisignal.aax4917
Source DB: PubMed Journal: Sci Signal ISSN: 1945-0877 Impact factor: 8.192